Cargando…
Detection of Pancreatic Cancer Biomarkers Using Mass Spectrometry
BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer-related deaths. Therefore, in order to improve survival rates, the development of biomarkers for early diagnosis is crucial. Recently, diabetes has been associated with an increased risk of pancreatic cancer. The aims of this study...
Autores principales: | Kim, Kiyoun, Ahn, Soohyun, Lim, Johan, Yoo, Byong Chul, Hwang, Jin-Hyeok, Jang, Woncheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285963/ https://www.ncbi.nlm.nih.gov/pubmed/25673969 http://dx.doi.org/10.4137/CIN.S16341 |
Ejemplares similares
-
Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry
por: Mun, Sora, et al.
Publicado: (2019) -
Mass spectrometry for the detection of potential psychiatric biomarkers
por: Ngounou Wetie, Armand G, et al.
Publicado: (2013) -
Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach
por: Park, Jisook, et al.
Publicado: (2017) -
The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014) -
Mass Spectrometry and Biomarker Development
por: Rodland, Karin D.
Publicado: (2004)